BioRestorative Therapies Inc. (NASDAQ: BRTX) Stock Information | RedChip

BioRestorative Therapies Inc. (NASDAQ: BRTX)


$1.4600
+0.0100 ( +1.74% ) 4.8K

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Market Data


Open


$1.4600

Previous close


$1.4500

Volume


4.8K

Market cap


$9.94M

Day range


$1.4260 - $1.4800

52 week range


$1.0300 - $3.6699

SEC Filings


Form Type Description Pages Date
8-k 8K-related 19 Feb 08, 2024
8-k 8K-related 17 Feb 05, 2024
8-k 8K-related 17 Feb 01, 2024
4 Insider transactions 1 Dec 05, 2023

Latest News